{"pmid":32440972,"title":"Disinformation, Misinformation and Inequality-Driven Mistrust in the Time of COVID-19: Lessons Unlearned from AIDS Denialism.","text":["Disinformation, Misinformation and Inequality-Driven Mistrust in the Time of COVID-19: Lessons Unlearned from AIDS Denialism.","AIDS Behav","Jaiswal, J","LoSchiavo, C","Perlman, D C","32440972"],"journal":"AIDS Behav","authors":["Jaiswal, J","LoSchiavo, C","Perlman, D C"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32440972","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1007/s10461-020-02925-y","topics":["Prevention"],"weight":1,"_version_":1667535119557066752,"score":9.490897,"similar":[{"pmid":32478708,"title":"Curbing Misinformation and Disinformation in the COVID-19 Era: A View from Cuba.","text":["Curbing Misinformation and Disinformation in the COVID-19 Era: A View from Cuba.","As the COVID-19 health crisis engulfs the planet, we are sub-merged in a parallel pandemic: the glut of misinformation and disinformation. The data associated with this phenomenon are creating a disaster within a disaster. In early April 2020, the Span-ish news agency EFE[1] reported that over one million internet ac-counts were dedicated to rumor-mongering, spreading unverifi ed information about the coronavirus. From January through April 13, fact-checkers at Maldita.es[2] had tracked over 400 lies and false alerts circulated about COVID-19 in Spain alone.","MEDICC Rev","Alonso-Galban, Patricia","Alemany-Castilla, Claudia","32478708"],"abstract":["As the COVID-19 health crisis engulfs the planet, we are sub-merged in a parallel pandemic: the glut of misinformation and disinformation. The data associated with this phenomenon are creating a disaster within a disaster. In early April 2020, the Span-ish news agency EFE[1] reported that over one million internet ac-counts were dedicated to rumor-mongering, spreading unverifi ed information about the coronavirus. From January through April 13, fact-checkers at Maldita.es[2] had tracked over 400 lies and false alerts circulated about COVID-19 in Spain alone."],"journal":"MEDICC Rev","authors":["Alonso-Galban, Patricia","Alemany-Castilla, Claudia"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478708","source":"PubMed","week":"202023|Jun 01 - Jun 07","locations":["Spain","Cuba"],"countries":["Spain","Cuba"],"countries_codes":["ESP|Spain","CUB|Cuba"],"weight":0,"_version_":1668532089440436224,"score":68.43202},{"pmid":32474977,"title":"Information and Disinformation: Social Media in the COVID-19 Crisis.","text":["Information and Disinformation: Social Media in the COVID-19 Crisis.","The novel coronavirus disease of 2019 (COVID-19) is a global pandemic with over 4.7 million cases and 316,000 deaths worldwide.(1) Social media, defined as \"electronic communication through which users create online communities to share information, ideas, personal messages, and other content,\"(2) has played an important role during the COVID-19 pandemic. In fact, social media usage amongst the public has previously been demonstrated to significantly increase in cases of natural disasters and crises.(3) However, it is important to consider the benefits and limitations of this medium.","Acad Emerg Med","Gottlieb, Michael","Dyer, Sean","32474977"],"abstract":["The novel coronavirus disease of 2019 (COVID-19) is a global pandemic with over 4.7 million cases and 316,000 deaths worldwide.(1) Social media, defined as \"electronic communication through which users create online communities to share information, ideas, personal messages, and other content,\"(2) has played an important role during the COVID-19 pandemic. In fact, social media usage amongst the public has previously been demonstrated to significantly increase in cases of natural disasters and crises.(3) However, it is important to consider the benefits and limitations of this medium."],"journal":"Acad Emerg Med","authors":["Gottlieb, Michael","Dyer, Sean"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474977","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/acem.14036","weight":0,"_version_":1668341932679495682,"score":49.506695},{"pmid":32436485,"title":"Coronavirus Conspiracy Beliefs, Mistrust, and Compliance with Government Guidelines in England.","text":["Coronavirus Conspiracy Beliefs, Mistrust, and Compliance with Government Guidelines in England.","Psychol Med","Freeman, Daniel","Waite, Felicity","Rosebrock, Laina","Petit, Ariane","Causier, Chiara","East, Anna","Jenner, Lucy","Teale, Ashley-Louise","Carr, Lydia","Mulhall, Sophie","Bold, Emily","Lambe, Sinead","32436485"],"journal":"Psychol Med","authors":["Freeman, Daniel","Waite, Felicity","Rosebrock, Laina","Petit, Ariane","Causier, Chiara","East, Anna","Jenner, Lucy","Teale, Ashley-Louise","Carr, Lydia","Mulhall, Sophie","Bold, Emily","Lambe, Sinead"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436485","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1017/S0033291720001890","locations":["England"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"weight":0,"_version_":1667521393826201600,"score":47.798622},{"pmid":32412509,"title":"COVID-19 Comes 40 Years After AIDS - Any Lesson?","text":["COVID-19 Comes 40 Years After AIDS - Any Lesson?","The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being \"with\" rather than \"by\" SARS-CoV-2 infection. They are often the result of inadequate health care due to overwhelming demands. To date, there is no specific therapy for SARS-CoV-2 infection. Several antivirals are being tested clinically, including remdesivir, at this time the most promising. For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. The benefit of orticosteroids, hydroxychloroquine, etc., is limited. Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic.","AIDS Rev","Soriano, Vicente","Barreiro, Pablo","Ramos, Jose Manuel","Eiros, Jose M","de Mendoza, Carmen","32412509"],"abstract":["The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being \"with\" rather than \"by\" SARS-CoV-2 infection. They are often the result of inadequate health care due to overwhelming demands. To date, there is no specific therapy for SARS-CoV-2 infection. Several antivirals are being tested clinically, including remdesivir, at this time the most promising. For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. The benefit of orticosteroids, hydroxychloroquine, etc., is limited. Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic."],"journal":"AIDS Rev","authors":["Soriano, Vicente","Barreiro, Pablo","Ramos, Jose Manuel","Eiros, Jose M","de Mendoza, Carmen"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32412509","source":"PubMed","week":"202020|May 11 - May 17","e_drugs":["Hydroxychloroquine","tocilizumab","remdesivir","lopinavir-ritonavir drug combination"],"topics":["Treatment"],"weight":1,"_version_":1666989866084204544,"score":43.213066},{"pmid":32233915,"title":"Editorial: Managing the march of COVID-19: lessons from the HIV and AIDS epidemic.","text":["Editorial: Managing the march of COVID-19: lessons from the HIV and AIDS epidemic.","Afr J AIDS Res","Whiteside, Alan","Parker, Warren","Schramm, Mike","32233915"],"journal":"Afr J AIDS Res","authors":["Whiteside, Alan","Parker, Warren","Schramm, Mike"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32233915","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.2989/16085906.2020.1749792","topics":["Prevention"],"weight":1,"_version_":1666138490331463680,"score":41.898624}]}